Integrating Medical and Behavioral Health (3 CME/CE Credit)
This course begins with a foundational overview of addictive disorders, followed by a focused exploration of opioid addiction. The presenter will discuss the neurological and psychological processes underlying dependency, with particular attention to the neurochemistry specific to opioids. The session will then cover evidence-based treatment modalities for addiction. By understanding the risks and mechanisms of opioids, participants will be better equipped to support responsible prescribing practices and effective pain management.
https://nefesh.org/workshops/OpioidAddi433/viewFREE WEBINAR
Opioid Addiction and Treatment Innovations:
Integrating Medical and Behavioral Health (3 CME/CE Credit)
Previously Recorded
Presenter: Shimmy Feintuch, LCSW CASAC-G
Course Length: 3 Hours
Learning Objectives:
- Define the concept of dependence and demonstrate a comprehensive understanding of key dependence-related terminology.
- Differentiate opioid dependence from dependence on other classes of drugs by identifying specific characteristics and neurochemical processes unique to opioid addiction.
- Outline and discuss foundational approaches and evidence-based modalities for the treatment of opioid dependence, including harm reduction strategies, medication-assisted treatment, and the use of motivational interviewing techniques.
This workshop Offers 3 Continuing Education Credits
This webinar is recorded and will not grant live credits.
This course begins with a foundational overview of addictive disorders, followed by a focused exploration of opioid addiction. The presenter will discuss the neurological and psychological processes underlying dependency, with particular attention to the neurochemistry specific to opioids. The session will then cover evidence-based treatment modalities for addiction. By understanding the risks and mechanisms of opioids, participants will be better equipped to support responsible prescribing practices and effective pain management.
Learning Objectives:
- Define the concept of dependence and demonstrate a comprehensive understanding of key dependence-related terminology.
- Differentiate opioid dependence from dependence on other classes of drugs by identifying specific characteristics and neurochemical processes unique to opioid addiction.
- Outline and discuss foundational approaches and evidence-based modalities for the treatment of opioid dependence, including harm reduction strategies, medication-assisted treatment, and the use of motivational interviewing techniques.
Agenda:
- Understanding Addiction (30 Minutes)
- Definitions
- Models for understanding addiction
- Opioid Dependence (80 Minutes)
- Similarities and differences from other dependencies (30 min)
- Neurochemistry (30 min)
- Specific risk factors in opioid use (20 min)
- The impact of opioids on the individual, family, community, and greater society (20 min)
- Treatment Approaches (70 Minutes)
- Harm Reduction vs. Abstinence (20 min)
- Medication-Assisted Treatment (20 min)
- Motivational Interviewing (30 min)
This presentation is open to:
- Physicians
- Physician Assistance
- Nurses
- Social Workers
- Professional Counselors
- Therapists
- Psychologists
- Licensed Mental Health Practitioners
- Medical Doctors and Other Health Professionals
- Other professionals interacting with populations engaged in mental health based services
- New practitioners who wish to gain enhanced insight surrounding the topic
- Experienced practitioners who seek to increase and expand fundamental knowledge surrounding the subject matter
- Advanced practitioners seeking to review concepts and reinforce practice skills and/or access additional consultation
- Managers seeking to broaden micro and/or macro perspectives
Participants will receive their certificate electronically upon completion of the webinar and course evaluation form.
CE You!
Live Webinar:
Opioid Addiction and Treatment Innovations:
Integrating Medical and Behavioral Health (3 CME/CE Credit)
December 12, 2024
Online
Accreditation Statement

Amedco LLC designates this live activity / enduring material for a maximum of 3 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- NEFESH International, Inc. is recognized by the New York State Education Department's State Board for Psychology as an approved provider of continuing education for licensed psychologists #PSY-0116.
- NEFESH International is recognized by the New York State Education Department's State Board for Mental Health Practitioners as an approved provider of continuing education for licensed marriage and family therapists #MFT-0046
- NEFESH International is recognized by the New York State Education Department's State Board for Mental Health Practitioners as an approved provider of continuing education for Mental Health Counselor #MHC-0082
- NEFESH International is recognized by the New York State Education Department's State Board for Social Work as an approved provider of continuing education for licensed social workers #SW-0048.
- CE You! is an approved sponsor of the Maryland Board of Social Work Examiners for continuing education credits for licensed social workers in Maryland.
CE You! maintains responsibility for this program. - In support of improving patient care, this activity has been planned and implemented by
Amedco LLC and CE You! Amedco LLC is jointly accredited by the Accreditation Council for
Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education
(ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing
education for the healthcare team. Successful completion of this program qualifies for up
to 3 AMA PRA Category 1 Credit(s)TM.
Amedco LLC certifies that the attendee named above has participated in the enduring activity titled Opioid Addiction and Treatment Innovations:
Integrating Medical and Behavioral Health (3 CME/CE Credit), online, between September 10, 2021 and March 10, 2025 and is awarded the number of AMA PRA Category 1 CreditsTM listed above. National JA Provider # 4008163.